tert-Butyl 4-amino-5-methylazepane-1-carboxylate

Catalog No.: 
ACTHSP893
CAS No.: 
1228453-28-8
Molecular Formula: 
C12H24N2O2
Molecular Weight: 
228.34
tert-Butyl 4-amino-5-methylazepane-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$637.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-amino-5-methylazepane-1-carboxylate
IUPAC Nametert-butyl 4-amino-5-methylazepane-1-carboxylate
Molecular FormulaC12H24N2O2
Molecular Weight228.34
SMILESO=C(N1CCC(N)C(C)CC1)OC(C)(C)C
InChI KeyLXHKJNUHNLXPDI-UHFFFAOYSA-N
SynonymTert-Butyl 4-Amino-5-Methylazepane-1-Carboxylate;Tert-Butyl 4-Amino-5-Methylazepane-1-Carboxylate(WX601216);1H-Azepine-1-carboxylic acid, 4-aminohexahydro-5-methyl-, 1,1-dimethylethyl ester
CAS No.1228453-28-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACTHSP893 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACTHSP893 route product structure diagram
    ACTHSP8931228453-28-8
Inquiry

2. ACTHSP893 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACTHSP893 route product structure diagram
    ACTHSP8931228453-28-8
Inquiry

3. ACTHSP893 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTHSP893 route product structure diagram
    ACTHSP8931228453-28-8
Inquiry

Comments (0)